SEC Form 3 · accession 0001104659-16-093327
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jianxin Yang
Officer — Sr. VP, Head of Clinical Dev.
Period of report
Feb 2, 2016
Accepted (ET)
Feb 2, 2016 · 7:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | holding | — | — | — | 200,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1 | $0.01 | holding | — | — | — | — | May 22, 2024 | Ordinary Shares | 800,000 | — | D |
| Share Option (Right to Buy)F2 | $0.50 | holding | — | — | — | — | Jun 29, 2025 | Ordinary Shares | 125,000 | — | D |
Explanation of responses
- F1These securities vest over a five-year period as follows: 20% on July 7, 2015, and the remaining in 48 successive equal monthly installments, subject to continued service.
- F2These securities vest over a five-year period as follows: 20% on June 29, 2016, and the remaining in 48 successive equal monthly installments, subject to continued service.
Remarks
Exhibit List - Exhibit 24.1 - Power of Attorney